NVNO (enVVeno Medical Corporation Common Stock) Stock Analysis - SEC Filings

enVVeno Medical Corporation Common Stock (NVNO) is a publicly traded Healthcare sector company. As of May 21, 2026, NVNO trades at $10.95 with a market cap of $6.56M and a P/E ratio of -0.30. NVNO moved -1.77% today. Year to date, NVNO is -10.61%; over the trailing twelve months it is -91.38%. Its 52-week range spans $8.67 to $196.70. Rallies surfaces NVNO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find NVNO SEC filings?

Rallies organizes NVNO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

NVNO Key Metrics

Key financial metrics for NVNO
MetricValue
Price$10.95
Market Cap$6.56M
P/E Ratio-0.30
EPS$-33.06
Dividend Yield0.00%
52-Week High$196.70
52-Week Low$8.67
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-19.47M
Gross Margin0.00%

Latest NVNO News

Recent NVNO Insider Trades

  • Duhay Francis sold 140 (~$1.61K) on Mar 12, 2026.
  • Duhay Francis sold 4.90K (~$1.74K) on Dec 11, 2025.
  • Duhay Francis sold 4.90K (~$4.07K) on Sep 15, 2025.

NVNO Analyst Consensus

NVNO analyst coverage data. Average price target: $0.00.

Common questions about NVNO

Where can I find NVNO SEC filings?
Rallies organizes NVNO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show NVNO 10-K and 10-Q filings?
Rallies organizes NVNO SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is NVNO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NVNO. It does not provide personalized investment advice.
NVNO

NVNO